Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M166,057Revenue $M44,033Net Margin (%)10.0Z-Score3.1
Enterprise Value $M173,631EPS $1.5Operating Margin %14.4F-Score5
P/E(ttm))38.6Cash Flow Per Share $6.3Pre-tax Margin (%)12.6Higher ROA y-yN
Price/Book3.310-y EBITDA Growth Rate %3.1Quick Ratio1.4Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %-6.3Current Ratio2.0Lower Leverage y-yN
Price/Cash Flow7.1y-y EBITDA Growth Rate %-17.2ROA % (ttm)4.2Higher Current Ratio y-yY
Dividend Yield %3.1Insider Buy (3m)0ROE % (ttm)8.9Less Shares Outstanding y-yY
Payout Ratio %118Shares Outstanding M2,926ROI % (ttm)6.0Gross Margin Increase y-yN

Gurus Latest Trades with MRK

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MRKGeorge Soros 2013-12-31 Buy 0.06%$45.09 - $50.18
($47.86)
$ 56.4718%New holding, 150000 sh.150,000
MRKRuane Cunniff 2013-12-31 Buy $45.09 - $50.18
($47.86)
$ 56.4718%New holding, 4075 sh.4,075
MRKJean-Marie Eveillard 2013-12-31 Reduce-0.16%$45.09 - $50.18
($47.86)
$ 56.4718%Reduce -98.76%14,050
MRKLeon Cooperman 2013-12-31 Sold Out -0.15%$45.09 - $50.18
($47.86)
$ 56.4718%Sold Out0
MRKCharles Brandes 2013-12-31 Reduce-0.14%$45.09 - $50.18
($47.86)
$ 56.4718%Reduce -8.39%2,476,201
MRKJean-Marie Eveillard 2013-09-30 Reduce-0.16%$46.55 - $48.58
($47.88)
$ 56.4718%Reduce -49.6%1,134,041
MRKGeorge Soros 2013-09-30 Sold Out -0.13%$46.55 - $48.58
($47.88)
$ 56.4718%Sold Out0
MRKJoel Greenblatt 2013-09-30 Sold Out -0.05%$46.55 - $48.58
($47.88)
$ 56.4718%Sold Out0
MRKJames Barrow 2013-06-30 Add1.32%$44.35 - $49.44
($46.81)
$ 56.4721%Add 134.86%29,318,754
MRKCharles Brandes 2013-06-30 Add0.48%$44.35 - $49.44
($46.81)
$ 56.4721%Add 43.39%2,703,540
MRKGeorge Soros 2013-06-30 Buy 0.13%$44.35 - $49.44
($46.81)
$ 56.4721%New holding, 250000 sh.250,000
MRKJean-Marie Eveillard 2013-06-30 Add0.1%$44.35 - $49.44
($46.81)
$ 56.4721%Add 46.32%2,250,286
MRKPrem Watsa 2013-06-30 Add0.01%$44.35 - $49.44
($46.81)
$ 56.4721%Add 50%12,000
MRKLeon Cooperman 2013-06-30 Reduce-1.16%$44.35 - $49.44
($46.81)
$ 56.4721%Reduce -89.42%203,200
MRKJoel Greenblatt 2013-06-30 Reduce-0.04%$44.35 - $49.44
($46.81)
$ 56.4721%Reduce -44.15%23,739
MRKRay Dalio 2013-06-30 Sold Out -0.04%$44.35 - $49.44
($46.81)
$ 56.4721%Sold Out0
MRKJames Barrow 2013-03-31 Add0.99%$40.85 - $45.04
($42.8)
$ 56.4732%Add 38917.3%12,483,576
MRKLeon Cooperman 2013-03-31 Add0.9%$40.85 - $45.04
($42.8)
$ 56.4732%Add 225.64%1,921,300
MRKJean-Marie Eveillard 2013-03-31 Add0.23%$40.85 - $45.04
($42.8)
$ 56.4732%Add 10846%1,537,919
MRKRay Dalio 2013-03-31 Add0.02%$40.85 - $45.04
($42.8)
$ 56.4732%Add 117.35%95,941
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MRK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MRK George Soros 2013-12-31150,0000.010.06New Buy
MRK Ruane Cunniff 2013-12-314,07500New Buy
MRK Vanguard Health Care Fund 2013-12-3136,561,3481.255.7+1.79%
MRK John Hussman 2013-12-312,62500.01
MRK Prem Watsa 2013-12-3112,00000.05
MRK - CALLGeorge Soros 2013-12-31129,30000.06
MRK Mario Gabelli 2013-12-31195,6710.010.05
MRK James Barrow 2013-12-3129,423,8111.012.1-0.73%
MRK Dodge & Cox 2013-12-3148,798,4961.672.5-2.67%
MRK Charles Brandes 2013-12-312,476,2010.081.5-8.39%
MRK Jean-Marie Eveillard 2013-12-3114,05000-98.76%
MRK Leon Cooperman 2013-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FRAZIER KENNETH CChairman, President & CEO 2014-04-10Sell10,047$57.24-1.35view
Kuhlik Bruce NExe V-P & Gen Counsel 2014-04-04Sell145,225$56.430.07view
Golestani ClarkEVP & Chief Info Officer 2014-02-14Sell5,990$55.471.8view
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care 2014-02-13Sell43,870$55.042.6view
Canan JohnSr.V-P Finc-Global Controller 2014-02-11Sell10,000$55.71.38view
FRAZIER KENNETH CChairman, President & CEO 2014-02-11Sell41,520$54.523.58view
Schechter Adam HEVP & Pres-Global Human Health 2014-02-11Sell18,000$55.611.55view
WEEKS WENDELL PDirector 2014-02-10Sell5,000$54.264.07view
WENDELL PETER CDirector 2014-02-10Sell5,000$54.443.73view
Deese Willie AExe V-P & Pres. MMD 2014-02-10Sell50,000$54.683.27view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

    News about MRK:

    Articles On GuruFocus.com
    Bill Nygren Comments on Merck Apr 10 2014 
    Abbvie Inc. (ABBV) Dividend Stock Analysis Mar 21 2014 
    Top Owned Health Care Stocks of the Fourth Quarter Mar 07 2014 
    Top Three Holdings of a Top Investment Advisory Firm Mar 06 2014 
    GuruFocus Names Five Dividend Growers Mar 03 2014 
    An Industry Giant Re-Adapting to a New Scenario Feb 26 2014 
    Amgen Inc: As Good as It Gets? Feb 20 2014 
    Vanguard Health Care Fund’s Top Five Feb 10 2014 
    Jeff Auxier's Auxier Report Fourth Quarter 2013 Feb 06 2014 
    Top Five Guru-Held Health Care Stocks Dec 18 2013 

    More From Our Partners
    Eli Lilly/ Boehringer Drug Under FDA Review - Analyst Blog Apr 15 2014 - ZACKS

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Hide